LINZESS

Serial Number 77872111
Registration 4328588
800

Registration Progress

Application Filed
Nov 13, 2009
Under Examination
Jun 15, 2010
Approved for Publication
Apr 20, 2010
Published for Opposition
Apr 20, 2010
Registered
Apr 30, 2013

Basic Information

Serial Number
77872111
Registration Number
4328588
Filing Date
November 13, 2009
Registration Date
April 30, 2013
Published for Opposition
April 20, 2010
Renewal Date
April 30, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 18, 2023
Registration
Registered
Classes
005

Rights Holder

Ironwood Pharmaceuticals, Inc.

03
Address
100 Summer Street, Suite 2300
Boston, MA 02110

Ownership History

Ironwood Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Ironwood Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Ironwood Pharmaceuticals, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
John V. Hobgood, Esquire

USPTO Deadlines

Next Deadline
2853 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-04-30)
Due Date
April 30, 2033
Grace Period Ends
October 30, 2033

Application History

50 events
Date Code Type Description
Oct 18, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 18, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 18, 2023 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 18, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 18, 2023 E89R I TEAS SECTION 8 & 9 RECEIVED
Apr 30, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 26, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 26, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 26, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 26, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 26, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 8, 2019 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 8, 2019 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 7, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 26, 2019 E815 I TEAS SECTION 8 & 15 RECEIVED
Apr 30, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 30, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 26, 2013 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 25, 2013 ALIE A ASSIGNED TO LIE
Mar 25, 2013 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Mar 10, 2013 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 19, 2013 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 14, 2013 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 14, 2013 IUAF S USE AMENDMENT FILED
Dec 18, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2012 EX5G S SOU EXTENSION 5 GRANTED
Dec 15, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 15, 2012 EXT5 S SOU EXTENSION 5 FILED
Jun 16, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 15, 2012 EX4G S SOU EXTENSION 4 GRANTED
Jun 13, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 13, 2012 EXT4 S SOU EXTENSION 4 FILED
Dec 21, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2011 EX3G S SOU EXTENSION 3 GRANTED
Dec 11, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 11, 2011 EXT3 S SOU EXTENSION 3 FILED
Jun 14, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2011 EX2G S SOU EXTENSION 2 GRANTED
Jun 8, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 8, 2011 EXT2 S SOU EXTENSION 2 FILED
Jan 12, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 11, 2011 EX1G S SOU EXTENSION 1 GRANTED
Dec 12, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 12, 2010 EXT1 S SOU EXTENSION 1 FILED
Jun 15, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 20, 2010 PUBO A PUBLISHED FOR OPPOSITION
Apr 20, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2010 ALIE A ASSIGNED TO LIE

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syndrome [ gastrointestinal motility disorders and other gastrointestinal disorders ]
First Use Anywhere: Nov 26, 2012
First Use in Commerce: Nov 26, 2012

Classification

International Classes
005